Braden Michael Leonard, 10% Owner at AN2 Therapeutics, Inc. (ANTX), sold 2,632,000 shares at $1.16 ($3.0M) on 2025-05-28, disclosed to the SEC on 2025-05-30.
Open-market sale of $3.0M ANTX by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.16 | 100,000 | $116K | 3.9% |
| 2 | $1.16 | 100,000 | $116K | 3.9% |
| 3 | $1.16 | 2,000,000 | $2.3M | 77.6% |
| 4 | $1.01 | 425,000 | $429K | 14.4% |
| 5 | $1.03 | 7,000 | $7K | 0.2% |
| Total | $1.14 avg | 2,632,000 |
| $3.0M |
| 100% |
| Filing → |
| ADVM | SELL | 2025-12-03 | $3.6M | — | Filing → |
| ASTC | SELL | 2025-10-07 | $3.2M | — | Filing → |
| ANTX | SELL | 2025-06-16 | $436K | — | Filing → |